Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Research Articles

Original Research
Outcomes of Patients Treated For Critical Limb Ischemia in an Outpatient Endovascular Center
06/11/2018
Critical limb ischemia is present in only about 1% to 2% of all patients with peripheral arterial disease (PAD), but it is the most severe form of PAD and is responsible for 185,000 amputations in the United States each year.
Critical limb ischemia is present in only about 1% to 2% of all patients with peripheral arterial disease (PAD), but it is the most severe form of PAD and is responsible for 185,000 amputations in the United States each year.
Critical limb ischemia is...
06/11/2018
Vascular Disease Management
Original Research
Use of VASCADE Vascular Closure System for Venous Hemostasis
08/07/2017
The authors investigate whether vascular closure devices selected for characteristics optimal for venous closure can deliver a safe and effective way to achieve rapid hemostasis.
The authors investigate whether vascular closure devices selected for characteristics optimal for venous closure can deliver a safe and effective way to achieve rapid hemostasis.
The authors investigate whether...
08/07/2017
Vascular Disease Management
Original Research
A Multi-Regional Physician Survey of Peripheral Artery Disease: Implications for Improved Awareness and Expedited Referral
06/08/2017
Our aim was to determine awareness of PAD treatment options and referral of patients at high risk of PAD to specialty care via a cross-sectional online survey of 500 clinicians from across the United States.
Our aim was to determine awareness of PAD treatment options and referral of patients at high risk of PAD to specialty care via a cross-sectional online survey of 500 clinicians from across the United States.
Our aim was to determine...
06/08/2017
Vascular Disease Management
Original Research
A Multi-Regional Physician Survey of Peripheral Artery Disease: Implications for Improved Awareness and Expedited Referral
06/08/2017
Our aim was to determine awareness of PAD treatment options and referral of patients at high risk of PAD to specialty care via a cross-sectional online survey of 500 clinicians from across the United States.
Our aim was to determine awareness of PAD treatment options and referral of patients at high risk of PAD to specialty care via a cross-sectional online survey of 500 clinicians from across the United States.
Our aim was to determine...
06/08/2017
Vascular Disease Management
Original Research
Ultrasound-Guided Gas Sclerotherapy
04/06/2017
Ultrasound-guided gas sclerotherapy (UGGS) is a new method for sclerosing varicose veins. The objective of this method is to increase sclerosant contact with the venous endothelium to obtain the best sclerosing effect, achieved by a depletion...
Ultrasound-guided gas sclerotherapy (UGGS) is a new method for sclerosing varicose veins. The objective of this method is to increase sclerosant contact with the venous endothelium to obtain the best sclerosing effect, achieved by a depletion...
Ultrasound-guided gas...
04/06/2017
Vascular Disease Management
Original Research
The Peripheral RegIstry of Endovascular Clinical OutcoMEs (The PRIME Registry): Interim Analysis of the First 328 Subjects with Critical Limb Ischemia
03/15/2017
Subjects with critical limb ischemia (CLI) have high 1-year amputation and mortality rates.The clinical profile and outcomes of CLI subjects were characterized using the PRIME registry and compared with previous literature to highlight the...
Subjects with critical limb ischemia (CLI) have high 1-year amputation and mortality rates.The clinical profile and outcomes of CLI subjects were characterized using the PRIME registry and compared with previous literature to highlight the...
Subjects with critical limb...
03/15/2017
Vascular Disease Management
Original Research
Acute Results of Directional Atherectomy for the Treatment of Claudication and Critical Limb Ischemia in the DEFINITIVE LE Study
02/08/2017
This study assesses the acute safety of directional atherectomy for endovascular treatment of peripheral arterial disease in infrainguinal arteries.
This study assesses the acute safety of directional atherectomy for endovascular treatment of peripheral arterial disease in infrainguinal arteries.
This study assesses the acute...
02/08/2017
Vascular Disease Management
Original Research
Acute Results of Directional Atherectomy for the Treatment of Claudication and Critical Limb Ischemia in the DEFINITIVE LE Study
02/08/2017
This study assesses the acute safety of directional atherectomy for endovascular treatment of peripheral arterial disease in infrainguinal arteries.
This study assesses the acute safety of directional atherectomy for endovascular treatment of peripheral arterial disease in infrainguinal arteries.
This study assesses the acute...
02/08/2017
Vascular Disease Management
Original Research
Renal Denervation in Patients With Resistant Arterial Hypertension: a Single-Center Cohort Study and Learning Curve
08/07/2016
The authors evaluate the effect of percutaneous renal denervation in patients with resistant arterial hypertension in a prospective, single-center cohort study. The results showed a drop in office systolic blood pressure measurements. 
The authors evaluate the effect of percutaneous renal denervation in patients with resistant arterial hypertension in a prospective, single-center cohort study. The results showed a drop in office systolic blood pressure measurements. 
The authors evaluate the effect...
08/07/2016
Vascular Disease Management
Original Research
Review of Surgical Treatment of Popliteal Artery Injury: Outcomes of Open vs Endovascular Repair
08/07/2016
The authors examine outcomes of surgical and endovascular repair of popliteal artery injury and find that endovascular repair is increasingly being used.
The authors examine outcomes of surgical and endovascular repair of popliteal artery injury and find that endovascular repair is increasingly being used.
The authors examine outcomes of...
08/07/2016
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement